| 注册
首页|期刊导航|中国药业|穿心莲内酯磺化物雾化治疗急性加重期慢性阻塞性肺疾病的效果

穿心莲内酯磺化物雾化治疗急性加重期慢性阻塞性肺疾病的效果

陈贵华 刘益群

中国药业2013,Vol.22Issue(11):29-30,2.
中国药业2013,Vol.22Issue(11):29-30,2.

穿心莲内酯磺化物雾化治疗急性加重期慢性阻塞性肺疾病的效果

Observation on Clinical Effect of Andrographolide Sulfonate Nebulization in Treating Acute Exacerbation of COPD

陈贵华 1刘益群1

作者信息

  • 1. 重庆医科大学附属第二临床医院呼吸内科,重庆400010
  • 折叠

摘要

Abstract

Objective To investigate the clinical effect of andrographolide sulfonate nebulization in treating acute exacerbation of chronic obstructive pulmonary disease(AECOPD).Methods 96 patients with AECOPD were randomaly divided into the intervention group and the contol group,48 cases in each group.Afetr 7 d treatment,the life quality score,blood gas indexes and forced expiratory volume in 1 s (FEV1) percentage of predicted value were observed and compared between the two groups.Resluts The life quality scores in the intervention group were significantly superior to those in the control group with statistically significant difference(P< 0.05).Comparing the blood gas indexes and FEV1 percentage of predicted value after treatment,the difference between the intervention group and the control group had statistically significant difference(P < 0.05).Conclusion Andrographolide sulfonate nebulization has better effect in the treatment of AECOPD and deserves to be clinically promoted.

关键词

穿心莲内酯磺化物/雾化吸入/慢性阻塞性肺疾病

Key words

andrographolide sulfonate/ nebulization inhalation/ acute exacerbation of chronic obstructive pulmonary disease

分类

医药卫生

引用本文复制引用

陈贵华,刘益群..穿心莲内酯磺化物雾化治疗急性加重期慢性阻塞性肺疾病的效果[J].中国药业,2013,22(11):29-30,2.

基金项目

重庆市卫生局医学科技项目,项目编号:2009-2-176. ()

中国药业

OACSTPCD

1006-4931

访问量0
|
下载量0
段落导航相关论文